Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17866316 | 0.87 | HDAC1 (0.49) | ALDH1A1POLBTDP1L3MBTL1HDAC1 | |
| SCHEMBL9618235 | 0.83 | HDAC1 (0.56) | ALDH1A1POLBTDP1L3MBTL1HDAC1 | |
| SCHEMBL8179624 | 0.81 | POLB (0.59) | ALDH1A1POLBTDP1L3MBTL1CYP3A4 | |
| SCHEMBL9824905 | 0.81 | POLB (0.51) | ALDH1A1POLBTDP1L3MBTL1HDAC1 | |
| SCHEMBL28425954 | 0.81 | NAAA (0.55) | ALDH1A1POLBTDP1L3MBTL1HDAC1 | |
| SCHEMBL8167111 | 0.81 | HDAC1 (0.58) | ALDH1A1POLBTDP1L3MBTL1HDAC1 | |
| SCHEMBL9516913 | 0.79 | L3MBTL1 (0.58) | ALDH1A1POLBTDP1L3MBTL1HDAC1 | |
| SCHEMBL9277393 | 0.78 | TDP1 (0.50) | ALDH1A1POLBTDP1L3MBTL1HDAC1 | |
| SCHEMBL23528803 | 0.78 | ALDH1A1 (0.55) | ALDH1A1HPGDMAPTGAA | |
| SCHEMBL10441305 | 0.77 | HDAC1 (0.49) | ALDH1A1POLBTDP1L3MBTL1HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2462805-A1 | Formulations containing stabilised compounds containing iodine | LANXESS Deutschland GmbH (DE) | 2012-06-13 | — | — | EP | claimed |
| US-20230337680-A1 | PENFLUFEN AS A WOOD PRESERVATIVE AGAINST WOOD-DESTROYING BASIDIOMYCETES | LANXESS DEUTSCHLAND GMBH (DE) | 2023-10-26 | — | — | US | disclosed |
| US-11723368-B2 | Penflufen as a wood preservative against wood-destroying basidiomycetes | LANHESS Deutshcland GmbH | 2023-08-15 | — | — | US | disclosed |
| US-10829648-B2 | Succinate dehydrogenase inhibitor containing compositions | ARCH WOOD PROTECTION, INC. (US) | 2020-11-10 | — | — | US | disclosed |
| US-10798940-B2 | Penflufen polymer particles | LANXESS DEUTSCHLAND GMBH (DE) | 2020-10-13 | — | — | US | disclosed |
| EP-3344663-B1 | POLYMER PARTICLE CONTAINING PENFLUFEN | LANXESS DEUTSCHLAND GMBH (DE) | 2020-02-19 | — | — | EP | disclosed |
| EP-3344664-B1 | BIOCIDAL MIXTURES | LANXESS DEUTSCHLAND GMBH (DE) | 2019-09-25 | — | — | EP | disclosed |
| EP-3042562-B1 | PENFLUFEN CONTAINING COMPOSITIONS | ARCH WOOD PROTECTION INC (US) | 2019-08-28 | — | — | EP | disclosed |
| US-20190150453-A1 | PENFLUFEN AS A WOOD PRESERVATIVE AGAINST WOOD-DESTROYING BASIDIOMYCETES | LANXESS DEUTSCHLAND GMBH (DE) | 2019-05-23 | — | — | US | disclosed |
| EP-2919586-B1 | SUCCINATE DEHYDROGENASE INHIBITOR CONTAINING COMPOSITIONS | ARCH WOOD PROTECTION INC (US) | 2019-03-20 | — | — | EP | disclosed |
| WO-2002048100-A2 | THIOSULPHONIC S-ESTERS AS MATERIAL PROTECTIVE AGENT | BAYER AKTIENGESELLSCHAFT (DE) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002034731-A1 | 3-NITROISOXAZOLES AND THEIR USE IN THE PROTECTION OF MATERIALS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-05-02 | — | — | WO | disclosed |
| WO-2001046163-A2 | 3-NITRO-DIHYDRO-ISOXAZOLES AND OXAZINES AND THEIR USE AS MICROBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-06-28 | — | — | WO | disclosed |
| WO-2000064895-A1 | HETARYL-SUBSTITUTED DITHIAZOLE DIOXIDES USED AS PLANT PROTECTION AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-11-02 | — | — | WO | disclosed |
| US-6075019-A | Arylthio-dithiazindioxides and their use as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2000-06-13 | — | — | US | disclosed |
| EP-0984964-A1 | PYRIDYLTHIO-DITHIAZOLE DERIVATIVES ADN THEIR USE AS PEST CONTROL AGENTS | BAYER AG (DE) | 2000-03-15 | — | — | EP | disclosed |
| EP-0982995-A1 | ALGICIDES | Bayer Aktiengesellschaft (DE) | 2000-03-08 | — | — | EP | disclosed |
| WO-1998052945-A1 | PYRIDYLTHIO-DITHIAZOLE DERIVATIVES ADN THEIR USE AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-11-26 | — | — | WO | disclosed |
| WO-1998051154-A1 | ALGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-11-19 | — | — | WO | disclosed |
| EP-0286746-B1 | INSECTICIDAL N-(OPTIONALLY SUBSTITUTED) - N'-SUBSTITUTED-N,N'-DISUBSTITUTED- HYDRAZINES | ROHM AND HAAS COMPANY (US) | 1991-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11723368-B2 | Penflufen as a wood preservative against wood-destroying basidiomycetes | BLVRB, DCXR, PAH | ALDH1A1 199/4885POLB 3143/4885TDP1 2244/4885 |
| US-20230337680-A1 | PENFLUFEN AS A WOOD PRESERVATIVE AGAINST WOOD-DESTROYING BASIDIOMYCETES | BLVRB, DCXR, PAH | ALDH1A1 199/4885POLB 3143/4885TDP1 2244/4885 |
| US-20190150453-A1 | PENFLUFEN AS A WOOD PRESERVATIVE AGAINST WOOD-DESTROYING BASIDIOMYCETES | BLVRB, DCXR, PAH | ALDH1A1 199/4885POLB 3143/4885TDP1 2244/4885 |
| US-10798940-B2 | Penflufen polymer particles | FAP, PUF60, MATR3 | ALDH1A1 194/4885POLB 1092/4885TDP1 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.